Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 28, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury; Throat irritation; Chest discomfort NOS; Injection site s... | Outcome Unknown |
| Mar 27, 2024 | Human | Unknown | Maropitant Citrate | Injection site pain; Accidental exposure | Ongoing |
| Mar 26, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Tiredness; Confused; Closure, Abnormal; Accident... | Ongoing |
| Mar 26, 2024 | Human | Unknown | Pyrantel Pamoate;Sarolaner | Nausea | Outcome Unknown |
| Mar 26, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury | Outcome Unknown |
| Mar 25, 2024 | Human | Unknown | Frunevetmab | Needlestick injury | Outcome Unknown |
| Mar 22, 2024 | Human | Unknown | Doramectin | Needlestick injury; Injection site pain; Injection site oedema | Outcome Unknown |
| Mar 21, 2024 | Human | Unknown | Imidacloprid, Moxidectin | Swollen lip (see also Skin); Bumps on skin; Accidental exposure | Outcome Unknown |
| Mar 18, 2024 | Human | Unknown | Frunevetmab | Needlestick injury | Outcome Unknown |
| Mar 18, 2024 | Human | Unknown | Ceftiofur Hydrochloride | Needlestick injury; Hand and arm swollen; Bruising; Reddening of the skin | Outcome Unknown |
| Mar 18, 2024 | Human | Unknown | Frunevetmab | Needlestick injury | Outcome Unknown |
| Mar 17, 2024 | Human | Unknown | Oclacitinib Maleate | Anxious state of mind; Dry mouth; Accidental exposure | Outcome Unknown |
| Mar 16, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury | Outcome Unknown |
| Mar 15, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Tubes, Leaking; Accidental ... | Recovered/Normal |
| Mar 15, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury; Ecchymosis | Outcome Unknown |
| Mar 14, 2024 | Human | Unknown | Buprenorphine | Tingling skin | Ongoing |
| Mar 14, 2024 | Human | Unknown | Moxidectin | Vials, Abnormal; Accidental exposure; No sign | Recovered/Normal |
| Mar 14, 2024 | Human | Unknown | Oclacitinib Maleate | Dizziness; Accidental exposure | Outcome Unknown |
| Mar 14, 2024 | Human | Unknown | Fenbendazol Granules | Throat pain; Sinus pain; Nasal discharge; Migraine; Emesis (multiple) | Ongoing |
| Mar 14, 2024 | Human | Unknown | Buprenorphine | Tingling sensation | Outcome Unknown |
| Mar 13, 2024 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Medication error NOS; Closure, Abnormal; Acciden... | Recovered/Normal |
| Mar 13, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Warm feeling to the touch; Generalised rash; Dermatitis; Vascular dilation an... | Ongoing |
| Mar 13, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Localised rash; Swollen eye | Ongoing |
| Mar 12, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Closure, Abnormal; Accidental exposure; Medicati... | Recovered/Normal |
| Mar 11, 2024 | Human | Unknown | Moxidectin | Injection site swelling; Accidental exposure | Ongoing |
| Mar 11, 2024 | Human | Unknown | Ivermectin | Local swelling (not application site); High blood pressure; Accidental exposure | Outcome Unknown |
| Mar 8, 2024 | Human | Unknown | Oclacitinib Maleate | Nausea; Accidental exposure | Outcome Unknown |
| Mar 8, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Ongoing |
| Mar 7, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury; Injection site pain | Outcome Unknown |
| Mar 6, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error NOS; Accidental exposure | Recovered/Normal |
| Mar 5, 2024 | Human | Unknown | Oclacitinib Maleate | Vertigo | Recovered/Normal |
| Mar 5, 2024 | Human | Unknown | Imidacloprid, Moxidectin | Swollen lip (see also Skin); Accidental exposure | Ongoing |
| Mar 5, 2024 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Medication error NOS; Containers, Leaking; Produ... | Recovered/Normal |
| Mar 4, 2024 | Human | Unknown | Frunevetmab | Needlestick injury | Outcome Unknown |
| Mar 4, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Ongoing |
| Mar 4, 2024 | Human | Unknown | Omeprazole | Anaphylaxis | Outcome Unknown |
| Mar 2, 2024 | Human | Unknown | Praziquantel; Emodepside | Hives (see also Skin); Cough; Reddening of the skin; Itching; Accidental expo... | Outcome Unknown |
| Mar 1, 2024 | Human | Unknown | Bedinvetmab | Needlestick injury; Injection site pain | Outcome Unknown |
| Mar 1, 2024 | Human | Unknown | Ophytrium | Swollen eye; Odor, Abnormal | Outcome Unknown |
| Feb 29, 2024 | Human | Unknown | Selamectin;Sarolaner | Oedematous erythema; Pinnal erythema; Accidental drug intake by child | Outcome Unknown |
| Feb 27, 2024 | Human | Unknown | Melarsomine Dihydrochloride | Eye irritation; Application site irritation; Accidental exposure; Incorrect r... | Recovered/Normal |
| Feb 26, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Product defect, product dif... | Recovered/Normal |
| Feb 26, 2024 | Human | Unknown | Altrenogest Oily Solution | Headache; Night sweat | Ongoing |
| Feb 24, 2024 | Human | Unknown | Cefovecin | Needlestick injury; Injection site pruritus | Outcome Unknown |
| Feb 23, 2024 | Human | Unknown | Melarsomine Dihydrochloride | Injection site bleeding; Accidental exposure | Recovered/Normal |
| Feb 23, 2024 | Human | Unknown | Flunixin Meglumine Injectable | Eye redness; Eye irritation | Recovered/Normal |
| Feb 23, 2024 | Human | Unknown | Buprenorphine | Heavy sweating; Fatigue; Malaise | Recovered/Normal |
| Feb 23, 2024 | Human | Unknown | Enrofloxacin | Needlestick injury; Accidental exposure | Outcome Unknown |
| Feb 23, 2024 | Human | Unknown | Fluralaner Spot-On Solution | Application site burning sensation | Ongoing |
| Feb 22, 2024 | Human | Unknown | Fenbendazol Granules | Nausea | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.